Stock 6891 LOCUS CELL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Locus Cell Co., Ltd.

Equities

6891

TW0006891005

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
30.3 TWD +1.34% Intraday chart for Locus Cell Co., Ltd. -2.42% -3.81%
05-10 Locus Cell Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 Locus Cell Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Locus Cell Co Ltd is a Taiwan-based company mainly engaged in the biotechnology and pharmaceutical business. The Company is currently expected to provide cell therapy contract manufacturing organization (CDMO) production and development services using a pilot Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) good manufacturing practices (GMP) facility, with related technologies for cell therapy products (expected to include tissue engineering related products, CAR-T, iPSCs, MSC and other cell therapy applications), process development and process scale-up, analytical method development and validation, clinical GMP manufacturing process for clinical trials, and stability testing.

Number of employees: 33

Sales per Business

TWD in Million2022Weight2023Weight Delta
Cell Therapy-related Products
100.0 %
1 100.0 % 0 100.0 % -32.33%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
1 100.0 % 0 100.0 % -32.33%

Managers

Managers TitleAgeSince
Chih Hui Yang CEO
 Chief Executive Officer 46 -
Chun Wei Chen DFI
 Director of Finance/CFO - -
Heng Yu Liu CTO
 Chief Tech/Sci/R&D Officer - 14/11/21
An Chih Teng ADM
 Chief Administrative Officer - 30/06/21
I Chieh Tung AUD
 Comptroller/Controller/Auditor - 31/05/21

Members of the board

Members of the board TitleAgeSince
Hung Jen Yang BRD
 Director/Board Member 55 30/05/21
Ming Yu Huang BRD
 Director/Board Member - 18/01/22
Shih Chia Lin BRD
 Director/Board Member - 30/05/21
Hung Neng Ho CHM
 Chairman - -
Chen Lung Wu BRD
 Director/Board Member - 30/05/21
Chih Hui Yang CEO
 Chief Executive Officer 46 -
Tsan Lieh Huang BRD
 Director/Board Member - 30/05/21
Shih Fa Shen BRD
 Director/Board Member - 30/05/21
Wen Chung Hu BRD
 Director/Board Member - 30/03/22
Chun-Lung Wu BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 200,000,000 200,000,000 ( 100.00 %) 0 100.00 %

Company contact information

Locus Cell Co., Ltd.

19/F-12, No. 97, Section 1 Xintai 5th Road

221416, New Taipei

+

http://www.locus-cell.com
address Locus Cell Co., Ltd.(6891)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
LOCUS CELL CO., LTD. Stock Locus Cell Co., Ltd.
-3.81% 188M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.42% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.84% 106B
ARGENX SE Stock argenx SE
-1.05% 21.96B
BIONTECH SE Stock BioNTech SE
-14.15% 21.84B
GENMAB A/S Stock Genmab A/S
-5.29% 19.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.16% 18.08B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 17.71B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.99% 14.32B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.24% 12.42B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6891 Stock
  4. Company Locus Cell Co., Ltd.